SpringWorks Therapeutics, Inc. (SWTX) has 20 已知的内部人和机构持有人记录. 最大持有人为 OrbiMed Capital GP VI LLC 持有 5,753,739 股. 其他重要持有人包括 ORBIMED ADVISORS LLC 和 Bain Capital Life Sciences Investors, LLC.
过去12个月，内部人进行了 6 笔交易，涉及 SWTX 股票 — 6 笔买入 (价值为 RSU 奖励) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
SWTX 內部人持股
最大持股人
OrbiMed Capital GP VI LLC
5,753,739 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Orbimed Capital Gp Vi Llc |
Director |
5,753,739 |
2022-08-10 |
|
| 2 |
Orbimed Advisors Llc |
10 Percent Owner |
5,599,842 |
2022-09-14 |
|
| 3 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
4,831,307 |
2021-08-12 |
|
| 4 |
Islam Saqib |
Chief Executive Officer |
1,003,869 |
2025-03-05 |
|
| 5 |
Edris Badreddin |
Chief Operating Officer |
169,712 |
2025-03-05 |
|
| 6 |
Squinto Stephen P |
Director |
131,652 |
2022-05-20 |
|
| 7 |
Lynch Daniel |
Director |
93,004 |
2025-05-15 |
|
| 8 |
Ashar Bhavesh |
Chief Commercial Officer |
62,053 |
2025-02-24 |
|
| 9 |
Smith L. Mary |
Chief Development Officer |
60,000 |
2024-01-08 |
|
| 10 |
Cassidy James |
Chief Medical Officer |
50,615 |
2025-01-14 |
|
| 11 |
Austin Maury |
CFO |
50,000 |
2005-05-09 |
|
| 12 |
Burgess Michael F. |
Head of Research & Development |
49,584 |
2022-07-20 |
|
| 13 |
Renstrup Jens |
Chief Medical Officer |
48,600 |
2021-01-11 |
|
| 14 |
Weinstein Herschel S |
General Counsel & Secretary |
35,431 |
2025-01-14 |
|
| 15 |
Perier Francis I Jr |
Chief Financial Officer |
34,419 |
2025-01-14 |
|
| 16 |
Pichl Daniel |
Chief People Officer |
31,250 |
2025-02-12 |
|
| 17 |
Alban Carlos |
Director |
28,861 |
2025-05-15 |
|
| 18 |
Francis Perier I Jr |
Chief Financial Officer |
26,963 |
2022-01-11 |
|
| 19 |
Lewis-hall Freda C |
Director |
24,727 |
2025-05-15 |
|
| 20 |
Fuhrman Alan |
Director |
24,727 |
2025-05-15 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2025-05-14 |
Hambleton Julie |
Director |
限制性股票授予 (RSU) |
10,060 |
- |
- |
| 2025-05-14 |
Alban Carlos |
Director |
限制性股票授予 (RSU) |
10,060 |
- |
- |
| 2025-05-14 |
Lewis-hall Freda C |
Director |
限制性股票授予 (RSU) |
10,060 |
- |
- |
| 2025-05-14 |
Mackay Martin |
Director |
限制性股票授予 (RSU) |
10,060 |
- |
- |
| 2025-05-14 |
Fuhrman Alan |
Director |
限制性股票授予 (RSU) |
10,060 |
- |
- |
| 2025-05-14 |
Lynch Daniel |
Director |
限制性股票授予 (RSU) |
10,060 |
- |
- |
